FDAnews
www.fdanews.com/articles/127338-teva-pharma-announces-launch-of-generic-valtrex

Teva Pharma Announces Launch of Generic Valtrex

May 25, 2010
Teva Pharmaceutical Industries Tuesday announced FDA approval and commercial launch of its generic version of GlaxoSmithKline’s antiviral product, Valtrex (valacyclovir hydrochloride) Tablets 500 mg and 1 g.
StreetInsider